Related Guides
Continue your research with these related independent reviews.
Sublingual Semaglutide: What You Need to Know Before Choosing Under-Tongue Drops
Compounded sublingual semaglutide — placed under the tongue for absorption — appeals to patients who want to avoid needles. But the bioavailability claims are unverified by peer-reviewed research, and only a handful of telehealth providers offer it. Here's the honest breakdown.
The honest answer: sublingual is better than swallowed oral, but injectable still wins
Sublingual delivery bypasses some of the GI degradation that makes swallowed oral semaglutide so inefficient (~1% bioavailability). But no published clinical trials confirm how much sublingual semaglutide actually absorbs. Injectable semaglutide delivers ~94% of the dose — with over 5 years of clinical trial evidence behind it. Sublingual is a reasonable option for patients with true needle phobia who are willing to accept an uncertain bioavailability tradeoff.
Swallowed Oral
~1%
bioavailability
(Rybelsus, strict fasting)
Sublingual Drops
~10–30%?
claimed
(no published RCTs)
Injectable
~94%
bioavailability
(subcutaneous, verified)
Injectable bioavailability: Blundell et al., 2022 (pharmacokinetic studies). Sublingual claims: compounder literature only; no peer-reviewed human PK data.
How Sublingual Semaglutide Works
Sublingual means “under the tongue.” The route is well-established for certain drugs (nitroglycerin, buprenorphine) where rapid or enhanced mucosal absorption is needed. The principle: tissue under the tongue has a dense capillary network that can absorb some molecules directly into the bloodstream, bypassing the liver's first-pass metabolism and GI degradation.
For semaglutide — a large peptide molecule — the jury is out on how effective this route is. Peptides are generally too large to cross mucosal membranes efficiently, which is why the branded oral semaglutide (Rybelsus) still only achieves ~1% bioavailability even with Novo Nordisk's proprietary absorption enhancer (SNAC). Sublingual compounded semaglutide doesn't use SNAC — it relies on direct mucosal absorption, and no peer-reviewed pharmacokinetic study has confirmed how much actually makes it into circulation.
The SNAC gap
Rybelsus (Novo Nordisk's oral semaglutide) uses a proprietary absorption enhancer called sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC) that locally raises gastric pH and facilitates absorption. Even with SNAC, bioavailability is only ~1%. Compounded sublingual drops don't contain SNAC — their mechanism relies purely on mucosal absorption without a verified enhancer.
How to Take Sublingual Semaglutide
Protocol varies by compounding pharmacy, but the standard approach:
- 1Take on an empty stomach (morning, before food or other medications)
- 2Measure the prescribed dose using the provided dropper or syringe (no needle — just the oral syringe)
- 3Place the drops under the tongue, ideally against the sublingual vein
- 4Hold for 30–60 seconds — don't swallow immediately
- 5Swallow any remaining liquid
- 6Wait 15–30 minutes before eating (per your pharmacy's instructions)
Note: This is a general protocol. Always follow the specific instructions provided by your prescribing physician and compounding pharmacy.
Sublingual vs Injectable: Full Comparison
Verified May 6, 2026| Feature | Sublingual Drops | Injectable |
|---|---|---|
| Needle required | No | Yes (small, 4mm, once weekly) |
| Bioavailability | ~10-30% (claimed, unverified) | ~94% (verified in published studies) |
| Clinical trial evidence for weight loss | None for compounded sublingual form | Extensive (STEP-1, SUSTAIN trials) |
| Dosing schedule | Daily or weekly (varies) | Once weekly |
| Fasting required | Recommended on empty stomach | No |
| Available without insurance | Yes (compounded 503A) | Yes (compounded 503A) |
| Price range | $158–$300+/month | $99–$299/month |
| Providers offering it | TMates, DirectMeds (limited) | Strut, TMates, Eden, Embody, many more |
| FDA approval status | Not FDA-approved (compounded) | Not FDA-approved (compounded formulation) |
| Best for | True needle phobia, informed patients | Most patients — best evidence base |
What the Evidence Actually Shows
What is established
- • Injectable semaglutide produces ~14.9% weight loss at 68 weeks (STEP-1 trial, NEJM 2021)
- • Sublingual routes are effective for certain peptide drugs (e.g., oxytocin, desmopressin)
- • Semaglutide is degraded in the GI tract — the sublingual route plausibly reduces some of this degradation
What is not established
- • No published pharmacokinetic study confirms sublingual bioavailability of compounded semaglutide
- • No randomized controlled trials compare sublingual vs injectable semaglutide for weight loss
- • Compounder claims of 10–30% bioavailability are not backed by peer-reviewed human data
- • Semaglutide is a large peptide molecule — mucosal absorption of large peptides is inherently limited
Bottom line on efficacy
Sublingual semaglutide may work for some patients — but “may work” is not the same as “evidence-based.” If weight loss is your primary goal and you can tolerate needles (the weekly Wegovy/compounded injection needle is 4mm and essentially painless for most people), the injectable remains the most evidence-supported choice. Sublingual makes sense for patients with documented needle phobia who have been informed of the tradeoff.
Providers That Offer Sublingual Semaglutide
Fewer telehealth providers offer sublingual than injectable. Prices verified or estimated May 2026 — confirm current availability directly with each provider.
From $158/month (12-mo plan)
TMates explicitly offers both injectable and sublingual oral semaglutide options. One of the few telehealth providers that lets you choose your delivery format at intake. Strong patient support and highest EPC on Katalys ($16.09).
- Sublingual + injectable options
- 6.43% Katalys conversion rate
- Physician-supervised program
Pricing: verify directly
DirectMeds has historically offered sublingual/oral semaglutide formats alongside injectables. Verify current sublingual availability directly — offerings can change based on 503A pharmacy status and FDA guidance.
- Oral/sublingual formats historically available
- Confirm current availability at signup
From $99/month (injectable)
Strut offers injectable compounded semaglutide — the lowest-cost option we've verified. They do not currently offer sublingual semaglutide, but if you're open to injectable and cost is a priority, Strut is our top recommendation.
Affiliate disclosure: GLP1CompareHub earns a commission if you click through and enroll. See affiliate disclosure.
Who Is Sublingual Right For?
Consider sublingual if:
- Documented needle phobia that would prevent consistent weekly injection compliance
- You've tried and not tolerated the weekly injection format
- Your physician supports the sublingual route based on your medical history
- You understand and accept the lower (and unverified) bioavailability tradeoff
- You're comfortable with daily dosing rather than once-weekly
Stick with injectable if:
- Maximum weight loss efficacy is your primary goal
- You can manage a small once-weekly injection (most patients do fine)
- You want the format with the most clinical evidence
- You want more provider options and potentially lower cost ($99 vs $158+)
- You're managing a serious obesity-related health condition (T2D, cardiovascular)
Frequently Asked Questions
What is sublingual semaglutide?
Sublingual semaglutide is a compounded liquid or drop formulation of semaglutide that is placed under the tongue and held for 30–60 seconds before swallowing. The goal is to absorb semaglutide through the oral mucosa (the tissue under the tongue), bypassing some of the digestive degradation that limits the bioavailability of swallowed oral semaglutide tablets. It is not an FDA-approved formulation — it is prepared by 503A compounding pharmacies.
Is sublingual semaglutide as effective as the injection?
There are no published randomized controlled trials comparing compounded sublingual semaglutide to injectable semaglutide for weight loss. Injectable semaglutide has approximately 94% subcutaneous bioavailability, which is well-established. Sublingual bioavailability of semaglutide is not formally studied — compounders claim 10–30%, but these figures are not peer-reviewed. Until head-to-head trials exist, patients should understand the injectable remains the evidence-based choice for weight loss outcomes.
What is the bioavailability of sublingual vs injectable semaglutide?
Injectable semaglutide has approximately 94% subcutaneous bioavailability — this is well-documented in published pharmacokinetic studies. Swallowed oral semaglutide (Rybelsus) has approximately 1% bioavailability with strict fasting. Sublingual semaglutide occupies a theoretical middle ground: some absorption through the oral mucosa, but the actual bioavailability in humans is not established in peer-reviewed literature. Compounders cite 10–30% estimates, but this is not verified clinical data.
How do I take sublingual semaglutide?
Sublingual semaglutide is placed under the tongue using a dropper or measured dose. It is held under the tongue for 30–60 seconds to allow absorption through the oral mucosa, then swallowed. Taking it on an empty stomach is generally recommended to maximize any absorption. Specific protocols vary by compounding pharmacy — follow the instructions provided with your prescription.
Which telehealth providers offer sublingual semaglutide?
TMates is among the few telehealth providers that explicitly offers compounded sublingual semaglutide alongside their injectable option. DirectMeds also offers sublingual/oral formats — verify availability directly. Most providers (Strut Health, Eden Health, Embody) focus primarily on injectable compounded semaglutide, which has stronger evidence for weight loss outcomes.
Is sublingual semaglutide FDA approved?
No. There is no FDA-approved sublingual semaglutide product. Sublingual semaglutide is a 503A compounding pharmacy preparation. The FDA-approved semaglutide products are: Rybelsus (oral tablet, type 2 diabetes), Ozempic (injection, type 2 diabetes), and Wegovy (injection, obesity). Compounded formulations are legal under 503A pharmacy regulations but are not FDA-approved and lack the clinical trial data of the branded products.
Related Pages
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.